Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder

European Urology

Volumn 49, Issue 1, 2006, Pages 71-75

  Passerotti, Carlo C ^a,b   Bonfim, Alexandre ^a   Martins, João R M ^a   Dall'Oglio, Marcos F ^a   Sampaio, Lucia O ^a   Mendes, Aline ^a   Ortiz, Valdemar ^a   Srougi, Miguel ^a   Dietrich, Carl P ^a   Nader, Helena B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Transitional cell carcinoma; Transurethral resection; Urinary hyaluronan

Indexed keywords

BIOLOGICAL MARKER; HYALURONIC ACID;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; HUMANS; HYALURONIC ACID; MIDDLE AGED; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 29044448403     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.09.015     Document Type: Article

References (25)

1. J.Y. Ro, G.A. Staerkel, and A.G. Ayala Cytologic and histologic features of superficial bladder cancer Urol Clin North Am 19 3 1992 435 453
2. A.F. Althausen, G.R. Prout Jr., and J.J. Daly Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ J Urol 116 5 1976 575 580
3. W. Lutzeyer, H. Rubben, and H. Dahm Prognostic parameters in superficial bladder cancer: an analysis of 315 cases J Urol 127 2 1982 250 252
4. N.M. Heney, S. Ahmed, M.J. Flanagan, W. Frable, M.P. Corder, and M.D. Hafermann Superficial bladder cancer: progression and recurrence J Urol 130 6 1983 1083 1086
5. N.M. Heney, K. Proppe, G.R. Prout Jr., P.P. Griffin, and W.U. Shipley Invasive bladder cancer: tumor configuration, lymphatic invasion and survival J Urol 130 5 1983 895 897
6. N.M. Heney Natural history of superficial bladder cancer. Prognostic features and long-term disease course Urol Clin North Am 19 3 1992 429 433
7. R. Klan, V. Loy, and H. Huland Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder J Urol 146 2 1991 316 318
8. M.A. Zurkirchen, T. Sulser, A. Gaspert, and D. Hauri Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists Urol Int 72 2 2004 99 102
9. K. Yoshimura, N. Utsunomiya, K. Ichioka, Y. Matsui, A. Terai, and Y. Arai Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey Urology 65 2 2005 290 294
10. W. Oosterlinck Guidelines on diagnosis and treatment of superficial bladder cancer Minerva Urol Nefrol 56 1 2004 65 72
11. F.I. Rodriguez-Rubio Cortadellas, S. Garrido Insua, D. Rivas Aguayo, A. Hens Perez, J. Bachiller Burgos, and V. Beltran Aguilar Second resection in patients with Ta-T1 bladder tumors Actas Urol Esp 25 8 2001 553 558
12. H.W. Herr The value of a second transurethral resection in evaluating patients with bladder tumors J Urol 162 1 1999 74 76
13. G. Jakse, F. Algaba, P.U. Malmstrom, and W. Oosterlinck A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 45 5 2004 539 546 discussion 46
14. M.F. Lorenzo Gomez, and G. Schroeder The role of tumor markers in prognosing transitional bladder cancer Actas Urol Esp 27 7 2003 501 512
15. V.B. Lokeshwar, and M.S. Soloway Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 165 4 2001 1067 1077
16. V.B. Lokeshwar, C. Obek, H.T. Pham, D. Wei, M.J. Young, and R.C. Duncan Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade J Urol 163 1 2000 348 356
17. V.B. Lokeshwar, and N.L. Block HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade Urol Clin North Am 27 1 2000 53 61
18. J.R. Martins, C.C. Passerotti, R.M. Maciel, L.O. Sampaio, C.P. Dietrich, and H.B. Nader Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients Anal Biochem 319 1 2003 65 72
19. M.A. Simon, V.B. Lokeshwar, and M.S. Soloway Current bladder cancer tests: unnecessary or beneficial? Crit Rev Oncol Hematol 47 2 2003 91 107
20. G.L. Schroeder, M.F. Lorenzo-Gomez, S.H. Hautmann, M.G. Friedrich, S. Ekici, and H. Huland A side by side comparison of cytology and biomarkers for bladder cancer detection J Urol 172 3 2004 1123 1126
21. S. Sharma, C.D. Zippe, L. Pandrangi, D. Nelson, and A. Agarwal Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat J Urol 162 1 1999 53 57
22. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, and A. Ghafoor Cancer statistics, 2005 CA Cancer J Clin 55 1 2005 10 30
23. V.B. Lokeshwar, G.L. Schroeder, M.G. Selzer, S.H. Hautmann, J.T. Posey, and R.C. Duncan Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests Cancer 95 1 2002 61 72
24. S.H. Hautmann, V.B. Lokeshwar, G.L. Schroeder, F. Civantos, R.C. Duncan, and R. Gnann Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer J Urol 165 6 Pt 1 2001 2068 2074
25. T.C. Laurent, U.B. Laurent, and J.R. Fraser Serum hyaluronan as a disease marker Ann Med 28 3 1996 241 253